Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod at influenza vaccination site in untreated stage A CLL
2006-004902-16Phase 2Unknown
- Sponsor
- Royal Bournemouth Hospital
- Start
- Aug 2007
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of imiquimod in influenza and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (3 arms), sponsored by Royal Bournemouth Hospital. Primary endpoint: Antibody response rate to influenza vaccination in untreated stage A CLL vs healthy controls. Status: unknown.
02
Drugs
imiquimod
03
Conditions
influenzachronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2006-004902-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004902-16.